Mylan NL CEO Heather Bresch waits to testify before a House Oversight and Government Reform Committee hearing on the Rising Price of EpiPens, at the Capitol in Washington, U.S. September 21, 2016. REUTERS/Yuri Gripas

News, Photo and Web Search